Norah Palmateer

Reader

Glasgow Caledonian University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

ORCID

Google Scholar

About

Norah Palmateer is a Reader at Glasgow Caledonian University in the United Kingdom. Her research focuses on public health issues related to drug use, including the impact of opioid-agonist treatment and the prevalence of Hepatitis C and HIV among vulnerable populations. Recent articles authored by Dr. Palmateer examine factors influencing drug-related mortality, testing and treatment uptake during the COVID-19 pandemic, and the effects of non-prescribed medication use in Scotland.

Norah Palmateer

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Risk of drug-related mortality among people receiving opioid-agonist treatment during the COVID-19 pandemic in Scotland

Examining trends in the incidence of HIV infection among people with a history of drug use to inform an outbreak investigation and response: a retrospective cohort study

Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK

Association between antibody responses post-vaccination and severe COVID-19 outcomes in Scotland

Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study

Risk of drug-related death associated with co-prescribing of gabapentinoids and Z-drugs among people receiving opioid-agonist treatment: a national retrospective cohort study

Impact of the COVID-19 pandemic on HIV test uptake among people who inject drugs in the context of an HIV outbreak

SARS-CoV-2 vaccine uptake and risks of severe COVID-19 disease among people prescribed opioid agonist therapy in Scotland

Improved health‐related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durable

Increased risk of non-fatal overdose associated with non-prescribed benzodiazepine use in Scotland, UK.

Corrigendum to ‘Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs’ [J Hepatol 76 (2022) 549–557, (Journal of Hepatology (2022) 76(549-557) (S0168827821021036), (10.1016/j.jhep.2021.09.038))

Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study

Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020)

Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs

REDUCTION IN THE POPULATION PREVALENCE OF HCV VIRAEMIA AMONG PEOPLE WHO INJECT DRUGS ASSOCIATED WITH SCALE-UP OF DIRECT-ACTING ANTIVIRAL THERAPY IN COMMUNITY DRUG SERVICES: REAL WORLD DATA.

Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland

Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak

National population prevalence of antibodies to SARS-CoV-2 among pregnant women in Scotland during the second wave of the COVID-19 pandemic: a prospective national serosurvey

National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic

The uptake of foil from needle and syringe provision services and its role in smoking or snorting heroin among people who inject drugs in Scotland

Collaborators (13)

Becky Metcalfe

John Dillon

Ben Swallow

Sharon Hutchinson

Elliott Hall

Alan Yeung

Alison Munro

Matthew Hickman

Josephine-Louise Murray

Andrew McAuley

Daniela De Angelis

Colin Simpson

John Macleod

How do I reach out?

Meet Kite AI